Holders over time
- GH
- ELV
| Quarter | GH | ELV |
|---|---|---|
| Q3 2020 | 14 holders, $1.2bn | 30 holders, $15.0bn |
| Q4 2020 | 17 holders, $1.5bn | 29 holders, $16.7bn |
| Q1 2021 | 15 holders, $2.6bn | 25 holders, $18.6bn |
| Q2 2021 | 18 holders, $2.3bn | 30 holders, $19.4bn |
| Q3 2021 | 11 holders, $3.1bn | 26 holders, $18.5bn |
| Q4 2021 | 12 holders, $2.4bn | 29 holders, $23.3bn |
| Q1 2022 | 9 holders, $1.5bn | 31 holders, $23.9bn |
| Q2 2022 | 8 holders, $950m | 32 holders, $23.3bn |
| Q3 2022 | 9 holders, $1.3bn | 34 holders, $22.6bn |
| Q4 2022 | 11 holders, $731m | 34 holders, $25.5bn |
| Q1 2023 | 11 holders, $267m | 39 holders, $22.5bn |
| Q2 2023 | 14 holders, $752m | 38 holders, $20.6bn |
| Q3 2023 | 10 holders, $399m | 34 holders, $19.8bn |
| Q4 2023 | 9 holders, $433m | 36 holders, $20.3bn |
| Q1 2024 | 9 holders, $234m | 35 holders, $21.3bn |
| Q2 2024 | 9 holders, $323m | 33 holders, $22.1bn |
| Q3 2024 | 9 holders, $513m | 30 holders, $20.2bn |
| Q4 2024 | 11 holders, $599m | 32 holders, $15.9bn |
| Q1 2025 | 9 holders, $730m | 28 holders, $17.1bn |
| Q2 2025 | 10 holders, $843m | 27 holders, $14.8bn |
| Q3 2025 | 13 holders, $1.5bn | 27 holders, $12.7bn |
| Q4 2025 | 17 holders, $2.7bn | 25 holders, $17.0bn |
| Q1 2026 | 15 holders, $2.3bn | 26 holders, $13.6bn |
| Q2 2026 | 21 holders, $4.8bn | 28 holders, $17.7bn |
Guardant Health Inc
- Holders
- 11
- Reported value
- $599m
- Buyers
- 5
- Sellers
- 6
Breadth -1 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 32
- Reported value
- $15.9bn
- Buyers
- 20
- Sellers
- 12
Breadth +8 among 94 comparable managers.
Who holds both, Q4 2024
Both (7)
Artisan Partners LP, Baillie Gifford & Co, Man Group PLC, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC, Wellington Management Group LLP
Only GH (4)
ARK Investment Management LLC, Balyasny Asset Management LLC, PDT Partners LLC, Point72 Asset Management LP
Only ELV (25)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.